Loading...

501 posters, 2 videos, 1 audios, 8 topics, 37 sessions, 395 authors, 307 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

23rd Annual Pain Medicine Meeting 2024

November 21-23, 2024 | Caesars Palace, Las Vegas, Nevada

23rd Annual Pain Medicine Meeting 2024 banner

5742

SPINAL CORD STIMULATOR PERCUTANEOUS LEAD TRIAL IN PATIENT WITH VP SHUNT: A MEDICALLY CHALLENGING CASE

Part of Topic

Medically Challenging Cases

Spinal Cord Stimulator Percutaneous Lead Trial in Patient with VP Shunt: A Medically Challenging Case

 

Introduction

●Spinal cord stimulation (SCS)  is utilized for the management of complex cases of chronic pain refractory to other treatment options and surgical intervention
●The generator is inserted beneath the skin and the electrodes are inserted between the vertebrae and spinal cord
●Pulsed electrical energy from the SCS disrupts pain signals sent to the brain
●Patients with neurosurgical implanted devices have more risk factors associated with further instrumentation of spinal canal when placing the SCS
 

Methods

●Informed consent was obtained from patient in this case report
●Exempted from IRB review given lack of identifiable patient information per university policy
 

History and Physical Exam

●58-year-old  female with past medical history of HIV on HAART, communicating hydrocephalus managed with VP shunt/revision, chronic facet arthropathy, and depression who presented with refractory lower back pain radiating to bilateral buttocks
●Started 9 years ago without inciting trauma or preceding events
●Described as 8/10, “aching,” “burning,” and “throbbing” pain
●Exacerbated by walking and standing, and relieved by lumbar extension
●Notable for a positive bilateral Kemp’s test
●Treated by a prior pain specialist with physical therapy, medications (NSAIDs, Tylenol, muscle relaxants, neuropathic pain medications) and interventional techniques (medial branch blocks, epidural steroid injections) without improvement and with significant side effects
●Lumbosacral radiographs with bilateral L3-S1  facet arthropathy and lumbar MRI with severe facet arthrosis without central canal or foraminal stenosis
●Averse to trying alternative agents
●After discussion, psychological evaluation, and surgical clearance, patient elected to proceed with SCS trial
 

Intervention

●Bilateral octopolar 10kHz SCS leads placed percutaneously into posterior epidural space using fluoroscopic guidance and connected to external pulse generator
●Left lead placed at mid-point of T7, and right lead placed at superior endplate of T8
 

Results

●Leads remained in place for 7 days
●Experienced significant pain relief that decreased to 1/10 rating
●Significant functional improvement after trial
●No adverse effects or consequences to include infection or compromised neural function noted
●Plans to proceed with permanent implant
 

Discussion

●Identifying appropriate inclusion and exclusion criteria for neuromodulation can be challenging
●Guidelines suggest screening for psychiatric conditions like psychosis that could negatively impact treatment response
●Spinal canal entry in patients with VP shunts are associated with increased risk of infection
●Also, there is greater risk of acute spinal canal pressure increases, compromising spinal cord perfusion
 

Recommendations

●Consider short course of post-operative antibiotics in addition to prophylaxis during SCS placement for these patients
●Consistently evaluate for acute ICP increases from potential shunt kinking during prone positioning for this procedure
●Consider local anesthetics to prioritize early detection of shunt failure or changes in spinal perfusion pressure
23rd Annual Pain Medicine Meeting 2024 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.